Financial Snapshot

Revenue
$15.71B
TTM
Gross Margin
58.18%
TTM
Net Earnings
$1.175B
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
99.92%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$10.64B
Q3 2024
Cash
Q3 2024
P/E
37.79
Nov 29, 2024 EST
Free Cash Flow
$1.234B
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019
Revenue $14.95B $15.05B $14.47B $14.47B $14.32B
YoY Change -0.69% 4.06% 0.0% 1.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019
Revenue $14.95B $15.05B $14.47B $14.47B $14.32B
Cost Of Revenue $6.610B $6.587B $6.585B $6.585B $6.633B
Gross Profit $8.340B $8.467B $7.882B $7.882B $7.691B
Gross Profit Margin 55.79% 56.24% 54.48% 54.48% 53.69%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019
Selling, General & Admin $5.213B $5.061B $4.588B $4.588B $4.759B
YoY Change 3.0% 10.31% 0.0% -3.59%
% of Gross Profit 62.51% 59.77% 58.21% 58.21% 61.88%
Research & Development $375.0M $355.0M $320.0M $320.0M $391.0M
YoY Change 5.63% 10.94% 0.0% -18.16%
% of Gross Profit 4.5% 4.19% 4.06% 4.06% 5.08%
Depreciation & Amortization $644.0M $731.0M $746.0M $746.0M $709.0M
YoY Change -11.9% -2.01% 0.0% 5.22%
% of Gross Profit 7.72% 8.63% 9.46% 9.46% 9.22%
Operating Expenses $5.588B $5.416B $4.908B $4.908B $5.150B
YoY Change 3.18% 10.35% 0.0% -4.7%
Operating Profit $2.752B $3.051B $2.974B $2.974B $2.541B
YoY Change -9.8% 2.59% 0.0% 17.04%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019
Interest Expense -$42.00M -$20.00M -$40.00M -$40.00M $215.0M
YoY Change 110.0% -50.0% 0.0% -118.6%
% of Operating Profit -1.53% -0.66% -1.34% -1.34% 8.46%
Other Income/Expense, Net -$72.00M $5.000M
YoY Change -1540.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019
Pretax Income $2.637B $2.925B -$1.016B -$1.016B $2.120B
YoY Change -9.85% -387.89% 0.0% -147.92%
Income Tax $550.0M $894.0M -$137.0M -$137.0M $685.0M
% Of Pretax Income 20.86% 30.56% 32.31%
Net Earnings $2.087B $2.031B -$879.0M -$879.0M $1.435B
YoY Change 2.76% -331.06% 0.0% -161.25%
Net Earnings / Revenue 13.96% 13.49% -6.08% -6.08% 10.02%
Basic Earnings Per Share $1.20 $1.21
Diluted Earnings Per Share $1.11 $1.08 -$0.47 -$0.47 $0.76

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019
Cash & Short-Term Investments $1.231B $740.0M $618.0M $618.0M
YoY Change 66.35% 19.74% 0.0%
Cash & Equivalents $1.231B $740.0M $618.0M $618.0M
Short-Term Investments
Other Short-Term Assets $298.0M $411.0M $434.0M $434.0M
YoY Change -27.49% -5.3% 0.0%
Inventory $2.226B $1.702B $1.685B $1.685B
Prepaid Expenses
Receivables $2.122B $2.074B $1.858B $1.858B
Other Receivables $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $5.877B $4.927B $4.595B $4.595B
YoY Change 19.28% 7.23% 0.0%
Property, Plant & Equipment $1.930B $1.953B $2.113B $2.113B
YoY Change -1.18% -7.57% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $471.0M $538.0M $533.0M $533.0M
YoY Change -12.45% 0.94% 0.0%
Total Long-Term Assets $21.44B $23.00B $24.58B $24.58B
YoY Change -6.8% -6.43% 0.0%
Total Assets $27.32B $27.93B $29.18B $29.18B
YoY Change
Accounts Payable $1.829B $1.827B $1.579B $1.579B
YoY Change 0.11% 15.71% 0.0%
Accrued Expenses $2.097B $2.215B $5.915B $5.915B
YoY Change -5.33% -62.55% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.926B $4.042B $7.494B $7.494B
YoY Change -2.87% -46.06% 0.0%
Long-Term Debt $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $941.0M $1.058B $1.571B $1.571B
YoY Change -11.06% -32.65% 0.0%
Total Long-Term Liabilities $941.0M $1.058B $1.571B $1.571B
YoY Change -11.06% -32.65% 0.0%
Total Liabilities $7.295B $7.530B $10.82B $10.82B
YoY Change -3.12% -30.41% 0.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019
Basic Shares Outstanding 1.716B shares 1.716B shares
Diluted Shares Outstanding 1.716B shares 1.716B shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $44.404 Billion

About Kenvue Inc.

Kenvue, Inc. is a consumer health company. The company is headquartered in Skillman, New Jersey and currently employs 21,780 full-time employees. The company went IPO on 2023-05-04. The firm operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The firm has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

Industry: Perfumes, Cosmetics & Other Toilet Preparations Peers: BELLRING BRANDS, INC. COTY INC. e.l.f. Beauty, Inc. EDGEWELL PERSONAL CARE Co ESTEE LAUDER COMPANIES INC INTERPARFUMS INC NU SKIN ENTERPRISES, INC. OLAPLEX HOLDINGS, INC.